357401-10-6Relevant academic research and scientific papers
Practical synthesis of a potent indolocarbazole-based, DNA topoisomerase inhibitor
Akao, Atsushi,Hiraga, Shouichi,Iida, Takehiko,Kamatani, Asayuki,Kawasaki, Masashi,Mase, Toshiaki,Nemoto, Takayuki,Satake, Nobuya,Weissman, Steven A,Tschaen, David M,Rossen, Kai,Petrillo, Daniel,Reamer, Robert A,Volante
, p. 8917 - 8923 (2001)
DNA topoisomerase I inhibitors are currently under investigation as cancer chemotherapy agents of which indolocarbazole glycoside (1) has been identified as a promising candidate. A practical, scalable synthesis of 1 that limits the isolation of cytotoxic compounds to only that of the final product is described. The convergent process features a novel phase transfer-promoted glycosylation of aglycone core (4); subsequent hydrolysis provides anhydride (8). The hydrazine fragment (3), which is coupled with 8, is synthesized via a modification of existing procedures. The coupled product (2) is subsequently hydrogenated to provide 1 in excellent purity via direct crystallization (>99.3 A%).
PROCESS FOR PRODUCING INDOLOPYRROLOCARBAZOLE DERIVATIVE
-
Page/Page column 24-26, (2008/06/13)
The present invention relates to an industrially preferable process for producing an indolopyrrolocarbazole derivative represented by the formula (I): or a pharmaceutically acceptable salt thereof, which is useful as an anti-cancer agent. The above proce
